Ligand validation:9RCO

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 9RCO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9RCO_EDO_C_801	100%	87%	0.033	0.992	0.49	0.21	-	-	0	0	100%	1
9RCO_EDO_B_801	99%	80%	0.046	0.982	0.59	0.27	-	-	0	0	100%	1
9RCO_EDO_A_801	93%	76%	0.067	0.961	0.61	0.36	-	-	0	0	100%	1
9RCO_EDO_D_801	89%	75%	0.067	0.946	0.59	0.39	-	-	0	0	100%	1
9RCP_EDO_B_801	99%	82%	0.045	0.976	0.6	0.21	-	-	0	0	100%	1
9RCQ_EDO_A_801	99%	81%	0.053	0.981	0.52	0.31	-	-	1	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.5
3DPJ_EDO_F_193	100%	76%	0.023	0.995	0.41	0.53	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.